Hyalofast
by Anika Therapeutics S.R.L. 2 variants
Ref 144714F
Active
CE MDR CE MDD
Valid until
9 Feb 2030
FDA recalls
Not applicable
Documents
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR | NumberMDR 845084 | Date10 Aug 2026 | StatusActive |
| European Union | CE/MDD | NumberB-08033549790349 | Date20 Jul 2026 | StatusActive |
Certificates
- MDR 845084 Active
Technical documentation EU MDR
- Certifier
- BSI Group The Netherlands B.V. 2797
- Issued
- 10 Aug 2026
- Expires
- 9 Feb 2030
- Valid from
- 15 Aug 2026
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/MDR, CE/MDD Active
- Austria
- Belgium
- Bulgaria
- Czechia
- Denmark
- Estonia
- Finland
- Germany
- Greece
- Hungary
- Ireland
- Italy
- Latvia
- Lithuania
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- Slovenia
- Spain
- Sweden
- Türkiye
Specification
- Model / Reference
- 144714F
- Primary DI / UDI-DI
- 08033549790349, 08033549791131
- Basic UDI-DI
- B-08033549790349, 08033549HYALTHU
- EMDN Code
- P900401, P900402
- Device Class
- Class III
- EU market of registration
- Italy
Manufacturer details
- EUDAMED SRN
- IT-MF-000028141
Other devices from Anika Therapeutics S.R.L.
Properties
Other properties (11)
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- CMR Substance: No
- Human-derived: No
- Human Tissues: No
- Animal Tissues: No
- Endocrine Disruptor: No
- Administering Medicine: No
- Measuring Function: No
- Incorporates Medicinal Product: No